IP Library Granted Patent US 8,911,439
Granted Patent B2
US 8,911,439 · App. 12/944,666 · Granted Dec 16, 2014

Non-invasive and minimally invasive denervation methods and systems for performing the same

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,911,439
App. No.
12/944,666
Granted
Dec 16, 2014
Kind
B2
Abstract

A system and method can be used to denervate at least a portion of a bronchial tree. An energy emitter of an instrument is percutaneously delivered to a treatment site and outputs energy to damage nerve tissue of the bronchial tree. The denervation procedure can be performed without damaging non-targeted tissue. Minimally invasive methods can be used to open airways to improve lung function in subjects with COPD, asthma, or the like. Different sections of the bronchial tree can be denervated while leaving airways intact to reduce recovery times.

Claims (28)

1. A method for denervating a bronchial tree of a subject, comprising:

moving an energy emitter positioned at a distal section of an instrument through the subject's skin;

wrapping the distal section around an airway of the bronchial tree to position the energy emitter with respect to nerve tissue along the airway of the bronchial tree;

damaging the nerve tissue using energy from the energy emitter while the energy emitter is positioned outside of the airway; and

removing the instrument from the subject without severing the entire airway.

2. The method of claim 1 , further comprising leaving the airway intact throughout the denervation process.

3. The method of claim 1 , wherein damaging the nerve tissue comprises ablating a section of a nerve trunk to impede transmission of nervous system signals traveling along the airway.

4. The method of claim 1 , further comprising delivering at least one of radiofrequency energy, microwave energy, radiation energy, high intensity focused ultrasound energy, and thermal energy to damage the nerve tissue.

5. The method of claim 1 , further comprising:

percutaneously delivering the energy emitter proximate to the nerve tissue prior to damaging the nerve tissue.

6. The method of claim 1 , further comprising:

moving an intraluminal instrument through the subject's trachea and the airway; and

delivering energy between the energy emitter of the instrument outside the airway and the intraluminal instrument positioned within the airway to ablate the nerve tissue.

7. The method of claim 1 , wherein damaging the nerve tissue comprises irreversibly damaging nerve tissue between the subject's trachea and the subject's lung to at least partially block a transmission of nervous system signals and to cause a permanent decrease in smooth muscle tone of the portion of a bronchial tree.

8. The method of claim 1 , wherein damaging the nerve tissue comprises ablating the nerve tissue without passing the instrument through a wall of the airway.

9. The method of claim 1 , wherein damaging the nerve tissue comprises destroying the nerve tissue without substantially damaging blood vessels of the airway.

10. The method of claim 1 , wherein the nerve tissue is positioned along a main bronchus of the bronchial tree.

11. The method of claim 1 , further comprising visualizing the outside of the airway while positioning the energy emitter using a visualization device selected from a group consisting of a thoracoscope, an ultrasonic device, and a fluoroscopy system.

12. The method of claim 1 further comprising moving the energy emitter through a port, a cannula, or a sleeve extending through the skin.

13. A method comprising:

percutaneously delivering a distal section of an instrument through a subject's skin and wrapping the distal section of the instrument around an airway of a bronchial tree of the subject such that the distal section is positioned to damage nerve tissue of the bronchial tree; and

denervating a first portion of the bronchial tree using the instrument to substantially inhibit nervous system signals from traveling to a second portion of the bronchial tree.

14. The method of claim 13 , further comprising damaging a nerve trunk positioned along a main bronchus.

15. The method of claim 13 , wherein denervating comprises damaging nerve tissue positioned between the subject's trachea and lung.

16. The method of claim 13 , wherein denervating the portion of the bronchial tree comprises ablating a sufficient amount of nerve tissue to prevent nervous system signals from traveling to substantially all bronchial branches of the bronchial tree.

17. The method of claim 13 , further comprising denervating the first portion of the bronchial tree and removing the instrument without destroying the airway.

18. The method of claim 13 , wherein the distal section of the instrument is positioned through a port, a cannula, or a sleeve extending through the subject's skin.

19. The method of claim 13 , further comprising visualizing the outside of the airway while delivering the distal section using a visualization device selected from a group consisting of a thoracoscope, an ultrasonic device, and a fluoroscopy system.

Assignments (5)
SECURITY INTEREST Recorded Oct 16, 2024
From: NUVAIRA, INC.
To: INNOVATUS LIFE SCIENCES LENDING FUND 1, LP
Reel/Frame 069175/0918 →
SECURITY INTEREST Recorded Dec 21, 2021
From: NUVAIRA, INC.
To: INNOVATUS LIFE SCIENCES LENDING FUND 1, LP
Reel/Frame 058561/0979 →
CHANGE OF NAME Recorded Jun 20, 2017
From: HOLAIRA, INC.
To: NUVAIRA, INC.
Reel/Frame 042915/0068 →
CHANGE OF NAME Recorded Feb 6, 2013
From: INNOVATIVE PULMONARY SOLUTIONS, INC.
To: HOLAIRA, INC.
Reel/Frame 029768/0930 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 17, 2011
From: MAYSE, MARTIN L.; DIMMER, STEVEN C.
To: INNOVATIVE PULMONARY SOLUTIONS, INC.
Reel/Frame 025829/0005 →